Miscellaneous News

RSS
COVID-19 may not have appeared first in China, suggests new genomic study

COVID-19 may not have appeared first in China, suggests new genomic study

Class I HLA alleles shape CD8+ T cell repertoire in SARS-CoV-2 infection

Class I HLA alleles shape CD8+ T cell repertoire in SARS-CoV-2 infection

Most long COVID-19 sequelae affect people under 65, finds study

Most long COVID-19 sequelae affect people under 65, finds study

A new SARS-CoV-2 variant (HMN.19B) has been identified in France

A new SARS-CoV-2 variant (HMN.19B) has been identified in France

Vaccine candidate targeting SARS-CoV-2 nucleocapsid protein elicits protective immune response in animal model

Vaccine candidate targeting SARS-CoV-2 nucleocapsid protein elicits protective immune response in animal model

Applications of nanoparticles in combating COVID-19

Applications of nanoparticles in combating COVID-19

Could portable air filters promote clearance of SARS-CoV-2-contaminated aerosols indoors?

Could portable air filters promote clearance of SARS-CoV-2-contaminated aerosols indoors?

Study develops COVID-19 pandemic reopening strategies in California

Study develops COVID-19 pandemic reopening strategies in California

Researchers characterize a large set of therapeutic antibodies against SARS-CoV-2 variants

Researchers characterize a large set of therapeutic antibodies against SARS-CoV-2 variants

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

Study observes increase in Lyme disease-causing ticks across California’s woodlands and beaches

Study observes increase in Lyme disease-causing ticks across California’s woodlands and beaches

Can control theory explain differences in virulence and transmission of SARS-CoV-2?

Can control theory explain differences in virulence and transmission of SARS-CoV-2?

COVID-19 donor antibodies show broad cross-reactivity against SARS-CoV-2 variants and related viruses

COVID-19 donor antibodies show broad cross-reactivity against SARS-CoV-2 variants and related viruses

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

SARS-CoV-2 clade linked to disease severity in the early phase of the pandemic

SARS-CoV-2 clade linked to disease severity in the early phase of the pandemic

Some heart medications may facilitate SARS-CoV-2 infection through increasing ACE2 receptor levels

Some heart medications may facilitate SARS-CoV-2 infection through increasing ACE2 receptor levels

Nucleocapsid-based vaccines may prevent SARS-CoV-2 dissemination to distal organs

Nucleocapsid-based vaccines may prevent SARS-CoV-2 dissemination to distal organs

Researchers develop eleven SARS-CoV-2 RBD nanobodies using computational design

Researchers develop eleven SARS-CoV-2 RBD nanobodies using computational design

Researchers characterize India’s devastating second wave of COVID-19

Researchers characterize India’s devastating second wave of COVID-19

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.